HARARE – Zimbabwe Stock Exchange-listed health care products manufacturer Medtech Holdings Limited (Medtech) is disposing its subsidiary Zimbabwe Pharmaceuticals (Zimpharm) for $1 coupled with guarantees to settle the embattled unit’s debts. Last month Medtech announced that it had accepted a firm offer from an unnamed local firm for its stake in the loss-making Zimpharm. Zimpharm’s…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions